[Severe and resistant cutaneous involvement in dermatomyositis: value of intravenous immunoglobulins].
Castanet
J
J
Lacour
J P
JP
Ortonne
J P
JP
D003882:Dermatomyositis / Q000150:complications* / Q000188:drug therapy; D004351:Drug Resistance; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008875:Middle Aged; D012871:Skin Diseases / Q000188:drug therapy / Q000209:etiology*
D016756:Immunoglobulins, Intravenous
Atteinte cutanée sévère et résistante au cours d'une dermatomyosite: intérêt des immunoglobulines intraveineuses.